Botanic Healthcare, a Hyderabad-based nutraceutical company, has successfully raised INR 250 crore (approximately US$ 29 million) in a Series B funding round. This marks the company’s first private equity funding round and sets the stage for growth in the global nutraceutical market. The round was led by Stakeboat Capital, with additional investments from Abakkus Four2Eight Opportunities Fund and DS Group, a limited partner of Stakeboat Capital.
Botanic Healthcare Aims for Growth in Three Years
The investment will be channeled towards consolidating Botanic Healthcare’s group entities and accelerating its ambitious goal of achieving a 400% growth in revenue over the next three years. Gaurav Soni, Founder and Managing Director of Botanic Healthcare, emphasized the strategic importance of the funding.
“With this funding, we will expand our product offerings, strengthen our global footprint, and invest in advanced research to meet the evolving needs of our customers.”
Expanding Product Portfolio and Strategic Collaborations
A substantial portion of the capital will be allocated to enhancing Botanic Healthcare’s product portfolio, with a focus on research and development (R&D) and clinical research. The company plans to forge strategic collaborations and joint ventures to harness external expertise and further innovate its offerings. These efforts aim to deliver clinically validated botanical extracts for industries such as pharmaceuticals, functional foods and beverages, personal care, and more.
The company already offers a diverse range of products, including fruit powder extracts, natural colors, phytochemical (plant) extracts, standardized herbal extracts, natural spice extracts, and oleoresin (oil) extracts. Strengthening this portfolio will position Botanic Healthcare to meet increasing global demand for natural health solutions.
Focus on Talent and Innovation
To support its expansion, Botanic Healthcare is prioritizing talent acquisition across key departments such as research, development, production, quality assurance, and sales. This strategic hiring initiative is expected to bolster the company’s R&D pipeline, enabling the development of innovative products that align with market trends.
Global Market Presence
Botanic Healthcare has established a significant international presence, exporting products to markets in the United States, Australia, New Zealand, South Korea, and several European Union countries. With this funding, the company aims to deepen its penetration into existing markets and enter new ones, catering to the rising global demand for nutraceutical products.
Also read: Israeli Agrotech Firm Fermata Raises $10M to Build Digital Brain for Horticulture
Chandrasekar Kandasamy, Managing Partner at Stakeboat Capital, highlighted the alignment between Botanic Healthcare’s innovative approach and the growing demand for sustainable health solutions.
“Botanic plays a crucial role in advancing complementary healthcare across industries. Their focus on clinically proven botanical extracts will significantly impact the future of health and wellness.”
Industry Context and Outlook
The global nutraceutical market is witnessing rapid growth, driven by increasing consumer preference for natural health alternatives. Botanic Healthcare is well-positioned to capitalize on this trend, leveraging its expertise in natural products and commitment to quality. The company’s plans to invest in technology, R&D, and strategic partnerships are expected to accelerate its progress in becoming a key player in the industry.
This milestone funding round marks the beginning of a transformative phase for Botanic Healthcare, as it embarks on an aggressive expansion strategy to secure a larger share of the burgeoning nutraceutical market. With a clear vision for innovation and growth, the company is poised to make a lasting impact on the global health and wellness landscape.